IPP Bureau
Takeda appoints Rhonda Pacheco President of US Business Unit
By IPP Bureau - September 13, 2025
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
Biocon Foundation constructs new high school building in Karnataka
By IPP Bureau - September 13, 2025
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
Apollo Hospitals acquires IFC’s 3% share in Apollo Health and Lifestyle for Rs. 1,254 Cr
By IPP Bureau - September 13, 2025
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Biocon inaugurates first US manufacturing facility in New Jersey
By IPP Bureau - September 12, 2025
Aarti Drugs receives order from MPCB for closure of process at Tarapur unit
By IPP Bureau - September 12, 2025
The HCl gas is generated continuously which is absorbed in the water scrubber using a chilled falling film system
Shukra Pharmaceuticals inks distribution tie-up with Wockhardt
By IPP Bureau - September 12, 2025
The products include high-quality, advanced anti-infective formulations such as EMROK (Levonadifloxacin) and MIQNAF (Nafithromycin)
NATCO Pharma updates on acquisition of Adcock Ingram
By IPP Bureau - September 12, 2025
VedaBio to use Mammoth Biosciences’ CRISPR-based technology for diagnostic applications
By IPP Bureau - September 12, 2025
CRISPR-based detection enables highly specific molecular recognition
Kytopen collaborates with BlueWhale Bio for cell therapy manufacturing
By IPP Bureau - September 12, 2025
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
iRegene Therapeutics secures series B+ financing
By IPP Bureau - September 12, 2025
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
A.forall expands US generics portfolio
By IPP Bureau - September 12, 2025
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
LGC opens CAD $100 million organic chemistry Center of Excellence in Canada
By IPP Bureau - September 12, 2025
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Lonza appoints Jason Berndt as Head of Group Operations
By IPP Bureau - September 12, 2025
Maria Soler Nunez appointed as Chief Quality Officer
Briefs: Torrent Pharmaceuticals and Hemant Surgical Industries
By IPP Bureau - September 12, 2025
Hemant Surgical Industries receives order
Dr. Reddy’s acquires J&J’s Stugeron portfolio to foray into anti-vertigo segment
By IPP Bureau - September 11, 2025
The portfolio acquired includes Stugeron brand as well as its leading local brands STUGERON FORTE and STUGERON PLUS across 18 markets in the APAC and EMEA regions
